Omar Bakr, Lillian Gelberg, Shinobu Seragaki, Sarah Youn, Jenna Kawamoto, Marcie Hoppe, Lisa Altman, Kristin Kopelson, Folasade P. May, Brianna Cowan, Debika Bhattacharya – 4 April 2019
Megan G. Hofmeister, Brian R. Edlin, Eli S. Rosenberg, Elizabeth M. Rosenthal, Laurie K. Barker, Meredith A. Barranco, Eric W. Hall, Jonathan Mermin, A. Blythe Ryerson – 4 April 2019
Marit Kalisvaart, Andrea Schlegel, Palak J. Trivedi, Keith Roberts, Darius F. Mirza, Thamara Perera, John I. Isaac, James Ferguson, Jeroen Jonge, Paolo Muiesan – 4 April 2019 – The use of extended criteria donor (ECD) grafts has been associated with acute kidney injury (AKI) after liver transplantation. However, the relation between graft quality and development of chronic kidney disease (CKD) remains unknown. Therefore, the aim of this study was to analyze the impact of ECD grafts for CKD after liver transplantation.
Nadim Mahmud, Samantha Halpern, Rebecca Farrell, Kate Ventura, Arwin Thomasson, Heidi Lewis, Kim M. Olthoff, Matthew H. Levine, Susanna Nazarian, Vandana Khungar – 4 April 2019 – Hospital readmissions after liver transplantation (LT) are common and associated with increased morbidity and cost. High readmission rates at our center motivated a change in practice with adoption of a nurse practitioner (NP)–based posttransplant care program.
Hannah L. Paish, Lee H. Reed, Helen Brown, Mark C. Bryan, Olivier Govaere, Jack Leslie, Ben S. Barksby, Marina Garcia Macia, Abigail Watson, Xin Xu, Marco Y.W. Zaki, Laura Greaves, Julia Whitehall, Jeremy French, Steven A. White, Derek M. Manas, Stuart M. Robinson, Gabriele Spoletini, Clive Griffiths, Derek A. Mann, Lee A. Borthwick, Michael J.
Omar Bakr, Lillian Gelberg, Shinobu Seragaki, Sarah Youn, Jenna Kawamoto, Marcie Hoppe, Lisa Altman, Kristin Kopelson, Folasade P. May, Brianna Cowan, Debika Bhattacharya – 4 April 2019
Mamta K. Jain, Nicole E. Rich, Chul Ahn, Barbara J. Turner, Joanne M. Sanders, Brian Adamson, Lisa Quirk, Patrice Perryman, Noel O. Santini, Amit G. Singal – 4 April 2019 – Hepatitis C virus (HCV) testing in persons born from 1945 to 1965 has had limited adoption despite guidelines, particularly among racial/ethnic minorities and socioeconomically disadvantaged patients, who have a higher prevalence of disease burden. We examined the effectiveness of a multifaceted intervention to improve HCV screening in a large safety‐net health system.
Zita Galvin, Keyur Patel, Mamatha Bhat – 4 April 2019
Silvia Nardelli, Stefania Gioia, Lorenzo Ridola, Alessio Farcomeni, Manuela Merli, Oliviero Riggio – 4 April 2019
Victor Navarro, Bharathi Avula, Ikhlas Khan, Manisha Verma, Leonard Seeff, Jose Serrano, Andrew Stolz, Robert Fontana, Jawad Ahmad – 3 April 2019 – The U.S. Drug Induced Liver Injury Network assayed the contents of herbal and dietary supplements collected from patients enrolled into its prospective study. The aim was to determine the accuracy of product labels, and to identify known hepatotoxins. Using high‐performance liquid chromatography coupled with mass spectrometry to assay 272 product, 51% were found to be mislabeled; that is, to have chemical contents that did not match the label.